Kazuno Yoshio, Maeno Yoshio, Kawamori Hiroyuki, Takahashi Nobuyuki, Abramowitz Yigal, Babak Hariri, Kashif Mohammad, Chakravarty Tarun, Nakamura Mamoo, Cheng Wen, Friedman John, Berman Daniel, Makkar Raj R, Jilaihawi Hasan
Cedars-Sinai Medical Center, Heart Institute, Advanced Health Sciences Pavilion, 127 S. San Vicente Blvd, Third Floor, Suite A3414, Los Angeles, CA 90048, USA.
Cedars-Sinai Medical Center, Heart Institute, Advanced Health Sciences Pavilion, 127 S. San Vicente Blvd, Third Floor, Suite A3414, Los Angeles, CA 90048, USA
Eur Heart J Cardiovasc Imaging. 2016 Sep;17(9):1054-62. doi: 10.1093/ehjci/jew032. Epub 2016 Mar 21.
Stent-frame morphology of the newer-generation, balloon-expandable transcatheter heart valve (THV), the SAPIEN 3 (S3), after transcatheter aortic valve implantation (TAVI) is unknown. We evaluated the THV stent-frame morphology post TAVI of the S3 using multi-slice computed tomography (MSCT) compared with the prior-generation THV, SAPIEN XT (S-XT).
A total of 94 consecutive participants of RESOLVE registry (NCT02318342) had MSCT after balloon-expandable TAVI (S3 = 39 and S-XT = 55). The morphology of the THV stent-frame was evaluated for expansion area and eccentricity at the THV-inflow, native annulus, mid-THV and THV-outflow levels. Mean %-expansion area for the S3 and the S-XT was 100.9 ± 5.7 and 96.1 ± 5.5%, respectively (P < 0.001). In the S3 group, the THV-inflow level had the largest value of %-expansion area, which decreased from THV-inflow to mid-THV level (105.2 ± 6.4 to 96.5 ± 5.9%, P < 0.001). However, in the S-XT group, %-expansion area increased from THV-inflow level to mid-THV level (93.2 ± 6.2 to 95.1 ± 6.1%, P = 0.0058). On nominal delivery balloon volume, the S3 in 88.5% of cases had overexpansion at the THV-inflow level. The observed degree of THV oversizing of the S3 was significantly lower than the S-XT (6.3 ± 8.6 vs. 11.8 ± 8.5%, P = 0.0027). Nonetheless, the incidence of post-procedural paravalvular aortic regurgitation (PVR) ≥ mild following the S3 TAVI was also significantly lower than the S-XT TAVI (17.9 vs. 43.6%, P = 0.014).
The newer-generation, balloon-expandable device, the S3, has a flared inflow morphology, whereas the prior-generation device, the S-XT, has relatively constrained inflow morphology post TAVI. This may contribute to a lesser degree of PVR with the S3.
新一代球囊扩张式经导管心脏瓣膜(THV)SAPIEN 3(S3)在经导管主动脉瓣植入术(TAVI)后的支架框架形态尚不清楚。我们使用多层计算机断层扫描(MSCT)评估了S3在TAVI后的THV支架框架形态,并与前代THV SAPIEN XT(S-XT)进行了比较。
RESOLVE注册研究(NCT02318342)的94名连续参与者在接受球囊扩张式TAVI后进行了MSCT检查(S3组 = 39例,S-XT组 = 55例)。在THV流入、天然瓣环、THV中部和THV流出水平评估THV支架框架的形态,包括扩张面积和偏心度。S3和S-XT的平均扩张面积百分比分别为100.9±5.7%和96.1±5.5%(P<0.001)。在S3组中,THV流入水平的扩张面积百分比最大,从THV流入到THV中部水平逐渐降低(105.2±6.4%至96.5±5.9%,P<0.001)。然而,在S-XT组中,扩张面积百分比从THV流入水平到THV中部水平增加(93.2±6.2%至95.1±6.1%,P = 0.0058)。在标称输送球囊体积下,88.5%的S3病例在THV流入水平出现过扩张。观察到的S3的THV过大尺寸程度明显低于S-XT(6.3±8.6%对11.8±8.5%,P = 0.0027)。尽管如此,S3 TAVI后≥轻度的术后瓣周主动脉反流(PVR)发生率也明显低于S-XT TAVI(17.9%对43.6%,P = 0.014)。
新一代球囊扩张式装置S3具有扩张的流入形态,而前代装置S-XT在TAVI后具有相对受限的流入形态。这可能导致S3的PVR程度较轻。